Global iPSC-Derived Natural Killer Cells Supply, Demand and Key Producers, 2026-2032
The global iPSC-Derived Natural Killer Cells market size is expected to reach $ 1106 million by 2032, rising at a market growth of 30.3% CAGR during the forecast period (2026-2032).
iPSC-Derived Natural Killer (NK) Cells refer to NK-like immune effector cells generated from induced pluripotent stem cells (iPSCs) through sequential processes including hematopoietic differentiation, NK cell maturation, expansion, purification, and quality control. These cells can be applied in cancer immunotherapy, B-cell depletion research for autoimmune diseases, infectious disease modeling, and cell therapy manufacturing process development. Key advantages include a standardized cell source, strong batch-to-batch consistency, and high amenability to multi-gene engineering at the iPSC stage, such as CAR insertion, CD16 enhancement, IL-15 expression, and immune-evasion modifications. These cells also support cryopreserved off-the-shelf production. The product category is currently mainly positioned in research-use products, CDMO process platforms, and clinical-stage therapeutic candidates. The overall gross margin is approximately 60%.
The evolution of cancer immunotherapy from autologous CAR-T toward allogeneic, off-the-shelf, and repeat-dose cell therapies is driving iPSC-derived NK cells to become a key next-generation modality. Their core value lies in enabling scalable production from a single master cell bank, thereby reducing donor variability and manufacturing scheduling constraints. In addition, iPSC-derived NK cells can be combined with monoclonal antibodies, bispecific or multispecific NK cell engagers, CAR constructs, and other immune-modulating strategies, enabling applications across hematologic malignancies, solid tumors, and B-cell?mediated autoimmune diseases.
Competitive dynamics are shifting from basic NK cell generation toward advanced cell engineering design, GMP-scale manufacturing, post-thaw functional activity, and batch consistency control. Leading companies typically introduce multi-gene engineering at the iPSC stage, followed by closed-system suspension culture, automated differentiation processes, and standardized quality control to improve manufacturability. In the near term, commercial value is concentrated in clinical-grade cell banks, process development services, CDMO manufacturing, and clinical trial supply. Long-term success depends on demonstrating durable efficacy, safety, and improved tumor infiltration capability, particularly in solid tumor indications.
North America remains the dominant region for clinical translation and capital investment, while Japan, Australia, and China are advancing rapidly in iPSC cell banking, regulatory exploration, and domestic clinical programs. Key uncertainties include long-term safety, residual undifferentiated iPSC control, immune rejection risk, scalability costs, and regulatory approval pathways. If engineering strategies and manufacturing economics continue to improve, iPSC-derived NK cells are expected to establish a differentiated position within the allogeneic cell therapy landscape.
Report Scope
This report studies the global iPSC-Derived Natural Killer Cells production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for iPSC-Derived Natural Killer Cells and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of iPSC-Derived Natural Killer Cells that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global iPSC-Derived Natural Killer Cells total production and demand, 2021-2032, (K Dose)
Global iPSC-Derived Natural Killer Cells total production value, 2021-2032, (USD Million)
Global iPSC-Derived Natural Killer Cells production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global iPSC-Derived Natural Killer Cells consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: iPSC-Derived Natural Killer Cells domestic production, consumption, key domestic manufacturers and share
Global iPSC-Derived Natural Killer Cells production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global iPSC-Derived Natural Killer Cells production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global iPSC-Derived Natural Killer Cells production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global iPSC-Derived Natural Killer Cells market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fate Therapeutics, Century Therapeutics, Cartherics, Nuwacell Biotech, HebeCell, Healios, Cytovia Therapeutics, Shoreline Biosciences, Applied StemCell, Cellistic, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World iPSC-Derived Natural Killer Cells market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global iPSC-Derived Natural Killer Cells Market, By Region:
1. How big is the global iPSC-Derived Natural Killer Cells market?
2. What is the demand of the global iPSC-Derived Natural Killer Cells market?
3. What is the year over year growth of the global iPSC-Derived Natural Killer Cells market?
4. What is the production and production value of the global iPSC-Derived Natural Killer Cells market?
5. Who are the key producers in the global iPSC-Derived Natural Killer Cells market?
6. What are the growth factors driving the market demand?
iPSC-Derived Natural Killer (NK) Cells refer to NK-like immune effector cells generated from induced pluripotent stem cells (iPSCs) through sequential processes including hematopoietic differentiation, NK cell maturation, expansion, purification, and quality control. These cells can be applied in cancer immunotherapy, B-cell depletion research for autoimmune diseases, infectious disease modeling, and cell therapy manufacturing process development. Key advantages include a standardized cell source, strong batch-to-batch consistency, and high amenability to multi-gene engineering at the iPSC stage, such as CAR insertion, CD16 enhancement, IL-15 expression, and immune-evasion modifications. These cells also support cryopreserved off-the-shelf production. The product category is currently mainly positioned in research-use products, CDMO process platforms, and clinical-stage therapeutic candidates. The overall gross margin is approximately 60%.
The evolution of cancer immunotherapy from autologous CAR-T toward allogeneic, off-the-shelf, and repeat-dose cell therapies is driving iPSC-derived NK cells to become a key next-generation modality. Their core value lies in enabling scalable production from a single master cell bank, thereby reducing donor variability and manufacturing scheduling constraints. In addition, iPSC-derived NK cells can be combined with monoclonal antibodies, bispecific or multispecific NK cell engagers, CAR constructs, and other immune-modulating strategies, enabling applications across hematologic malignancies, solid tumors, and B-cell?mediated autoimmune diseases.
Competitive dynamics are shifting from basic NK cell generation toward advanced cell engineering design, GMP-scale manufacturing, post-thaw functional activity, and batch consistency control. Leading companies typically introduce multi-gene engineering at the iPSC stage, followed by closed-system suspension culture, automated differentiation processes, and standardized quality control to improve manufacturability. In the near term, commercial value is concentrated in clinical-grade cell banks, process development services, CDMO manufacturing, and clinical trial supply. Long-term success depends on demonstrating durable efficacy, safety, and improved tumor infiltration capability, particularly in solid tumor indications.
North America remains the dominant region for clinical translation and capital investment, while Japan, Australia, and China are advancing rapidly in iPSC cell banking, regulatory exploration, and domestic clinical programs. Key uncertainties include long-term safety, residual undifferentiated iPSC control, immune rejection risk, scalability costs, and regulatory approval pathways. If engineering strategies and manufacturing economics continue to improve, iPSC-derived NK cells are expected to establish a differentiated position within the allogeneic cell therapy landscape.
Report Scope
This report studies the global iPSC-Derived Natural Killer Cells production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for iPSC-Derived Natural Killer Cells and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of iPSC-Derived Natural Killer Cells that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global iPSC-Derived Natural Killer Cells total production and demand, 2021-2032, (K Dose)
Global iPSC-Derived Natural Killer Cells total production value, 2021-2032, (USD Million)
Global iPSC-Derived Natural Killer Cells production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global iPSC-Derived Natural Killer Cells consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: iPSC-Derived Natural Killer Cells domestic production, consumption, key domestic manufacturers and share
Global iPSC-Derived Natural Killer Cells production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global iPSC-Derived Natural Killer Cells production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global iPSC-Derived Natural Killer Cells production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global iPSC-Derived Natural Killer Cells market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fate Therapeutics, Century Therapeutics, Cartherics, Nuwacell Biotech, HebeCell, Healios, Cytovia Therapeutics, Shoreline Biosciences, Applied StemCell, Cellistic, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World iPSC-Derived Natural Killer Cells market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global iPSC-Derived Natural Killer Cells Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Non-Engineered iPSC-Derived NK Cells
- CAR-Engineered iPSC-Derived NK Cells
- CD16-Enhanced iPSC-Derived NK Cells
- Immune-Evasive iPSC-Derived NK Cells
- Multi-Functional iPSC-Derived NK Cells
- Healthy Donor iPSC Line
- GMP Master iPSC Bank
- Gene-Edited Universal iPSC Line
- HLA-Matched iPSC Bank
- Patient-Specific iPSC Line
- Hematologic Malignancies
- Solid Tumors
- Autoimmune Diseases
- Infectious Diseases
- Inflammation and Tissue Repair
- Other Research Uses
- Research-Use Cell Product
- Preclinical Candidate
- Clinical-Grade Drug Product
- CDMO Manufacturing Service
- Cell Bank and Starting Material
- Cancer Immunotherapy
- Autoimmune Disease Therapy
- Infectious Disease Research
- Drug Screening and Mechanism Studies
- Cell Therapy Process Development
- Other Applications
- Fate Therapeutics
- Century Therapeutics
- Cartherics
- Nuwacell Biotech
- HebeCell
- Healios
- Cytovia Therapeutics
- Shoreline Biosciences
- Applied StemCell
- Cellistic
1. How big is the global iPSC-Derived Natural Killer Cells market?
2. What is the demand of the global iPSC-Derived Natural Killer Cells market?
3. What is the year over year growth of the global iPSC-Derived Natural Killer Cells market?
4. What is the production and production value of the global iPSC-Derived Natural Killer Cells market?
5. Who are the key producers in the global iPSC-Derived Natural Killer Cells market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 iPSC-Derived Natural Killer Cells Introduction
1.2 World iPSC-Derived Natural Killer Cells Supply & Forecast
1.2.1 World iPSC-Derived Natural Killer Cells Production Value (2021 & 2025 & 2032)
1.2.2 World iPSC-Derived Natural Killer Cells Production (2021-2032)
1.2.3 World iPSC-Derived Natural Killer Cells Pricing Trends (2021-2032)
1.3 World iPSC-Derived Natural Killer Cells Production by Region (Based on Production Site)
1.3.1 World iPSC-Derived Natural Killer Cells Production Value by Region (2021-2032)
1.3.2 World iPSC-Derived Natural Killer Cells Production by Region (2021-2032)
1.3.3 World iPSC-Derived Natural Killer Cells Average Price by Region (2021-2032)
1.3.4 North America iPSC-Derived Natural Killer Cells Production (2021-2032)
1.3.5 Europe iPSC-Derived Natural Killer Cells Production (2021-2032)
1.3.6 China iPSC-Derived Natural Killer Cells Production (2021-2032)
1.3.7 Japan iPSC-Derived Natural Killer Cells Production (2021-2032)
1.3.8 India iPSC-Derived Natural Killer Cells Production (2021-2032)
1.3.9 India iPSC-Derived Natural Killer Cells Production (2021-2032)
1.3.10 South America iPSC-Derived Natural Killer Cells Production (2021-2032)
1.3.11 Middle East iPSC-Derived Natural Killer Cells Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 iPSC-Derived Natural Killer Cells Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 iPSC-Derived Natural Killer Cells Major Market Trends
2 DEMAND SUMMARY
2.1 World iPSC-Derived Natural Killer Cells Demand (2021-2032)
2.2 World iPSC-Derived Natural Killer Cells Consumption by Region
2.2.1 World iPSC-Derived Natural Killer Cells Consumption by Region (2021-2026)
2.2.2 World iPSC-Derived Natural Killer Cells Consumption Forecast by Region (2027-2032)
2.3 United States iPSC-Derived Natural Killer Cells Consumption (2021-2032)
2.4 China iPSC-Derived Natural Killer Cells Consumption (2021-2032)
2.5 Europe iPSC-Derived Natural Killer Cells Consumption (2021-2032)
2.6 Japan iPSC-Derived Natural Killer Cells Consumption (2021-2032)
2.7 South Korea iPSC-Derived Natural Killer Cells Consumption (2021-2032)
2.8 ASEAN iPSC-Derived Natural Killer Cells Consumption (2021-2032)
2.9 India iPSC-Derived Natural Killer Cells Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World iPSC-Derived Natural Killer Cells Production Value by Manufacturer (2021-2026)
3.2 World iPSC-Derived Natural Killer Cells Production by Manufacturer (2021-2026)
3.3 World iPSC-Derived Natural Killer Cells Average Price by Manufacturer (2021-2026)
3.4 iPSC-Derived Natural Killer Cells Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global iPSC-Derived Natural Killer Cells Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for iPSC-Derived Natural Killer Cells in 2025
3.5.3 Global Concentration Ratios (CR8) for iPSC-Derived Natural Killer Cells in 2025
3.6 iPSC-Derived Natural Killer Cells Market: Overall Company Footprint Analysis
3.6.1 iPSC-Derived Natural Killer Cells Market: Region Footprint
3.6.2 iPSC-Derived Natural Killer Cells Market: Company Product Type Footprint
3.6.3 iPSC-Derived Natural Killer Cells Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: iPSC-Derived Natural Killer Cells Production Value Comparison
4.1.1 United States VS China: iPSC-Derived Natural Killer Cells Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: iPSC-Derived Natural Killer Cells Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: iPSC-Derived Natural Killer Cells Production Comparison
4.2.1 United States VS China: iPSC-Derived Natural Killer Cells Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: iPSC-Derived Natural Killer Cells Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: iPSC-Derived Natural Killer Cells Consumption Comparison
4.3.1 United States VS China: iPSC-Derived Natural Killer Cells Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: iPSC-Derived Natural Killer Cells Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based iPSC-Derived Natural Killer Cells Manufacturers and Market Share, 2021-2026
4.4.1 United States Based iPSC-Derived Natural Killer Cells Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers iPSC-Derived Natural Killer Cells Production Value (2021-2026)
4.4.3 United States Based Manufacturers iPSC-Derived Natural Killer Cells Production (2021-2026)
4.5 China Based iPSC-Derived Natural Killer Cells Manufacturers and Market Share
4.5.1 China Based iPSC-Derived Natural Killer Cells Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers iPSC-Derived Natural Killer Cells Production Value (2021-2026)
4.5.3 China Based Manufacturers iPSC-Derived Natural Killer Cells Production (2021-2026)
4.6 Rest of World Based iPSC-Derived Natural Killer Cells Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based iPSC-Derived Natural Killer Cells Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers iPSC-Derived Natural Killer Cells Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers iPSC-Derived Natural Killer Cells Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World iPSC-Derived Natural Killer Cells Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Non-Engineered iPSC-Derived NK Cells
5.2.2 CAR-Engineered iPSC-Derived NK Cells
5.2.3 CD16-Enhanced iPSC-Derived NK Cells
5.2.4 Immune-Evasive iPSC-Derived NK Cells
5.2.5 Multi-Functional iPSC-Derived NK Cells
5.3 Market Segment by Type
5.3.1 World iPSC-Derived Natural Killer Cells Production by Type (2021-2032)
5.3.2 World iPSC-Derived Natural Killer Cells Production Value by Type (2021-2032)
5.3.3 World iPSC-Derived Natural Killer Cells Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY CELL SOURCE STRATEGY
6.1 World iPSC-Derived Natural Killer Cells Market Size Overview by Cell Source Strategy: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Cell Source Strategy
6.2.1 Healthy Donor iPSC Line
6.2.2 GMP Master iPSC Bank
6.2.3 Gene-Edited Universal iPSC Line
6.2.4 HLA-Matched iPSC Bank
6.2.5 Patient-Specific iPSC Line
6.3 Market Segment by Cell Source Strategy
6.3.1 World iPSC-Derived Natural Killer Cells Production by Cell Source Strategy (2021-2032)
6.3.2 World iPSC-Derived Natural Killer Cells Production Value by Cell Source Strategy (2021-2032)
6.3.3 World iPSC-Derived Natural Killer Cells Average Price by Cell Source Strategy (2021-2032)
7 MARKET ANALYSIS BY THERAPEUTIC INDICATION
7.1 World iPSC-Derived Natural Killer Cells Market Size Overview by Therapeutic Indication: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Therapeutic Indication
7.2.1 Hematologic Malignancies
7.2.2 Solid Tumors
7.2.3 Autoimmune Diseases
7.2.4 Infectious Diseases
7.2.5 Inflammation and Tissue Repair
7.2.6 Other Research Uses
7.3 Market Segment by Therapeutic Indication
7.3.1 World iPSC-Derived Natural Killer Cells Production by Therapeutic Indication (2021-2032)
7.3.2 World iPSC-Derived Natural Killer Cells Production Value by Therapeutic Indication (2021-2032)
7.3.3 World iPSC-Derived Natural Killer Cells Average Price by Therapeutic Indication (2021-2032)
8 MARKET ANALYSIS BY DEVELOPMENT AND DELIVERY FORMAT
8.1 World iPSC-Derived Natural Killer Cells Market Size Overview by Development and Delivery Format: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Development and Delivery Format
8.2.1 Research-Use Cell Product
8.2.2 Preclinical Candidate
8.2.3 Clinical-Grade Drug Product
8.2.4 CDMO Manufacturing Service
8.2.5 Cell Bank and Starting Material
8.3 Market Segment by Development and Delivery Format
8.3.1 World iPSC-Derived Natural Killer Cells Production by Development and Delivery Format (2021-2032)
8.3.2 World iPSC-Derived Natural Killer Cells Production Value by Development and Delivery Format (2021-2032)
8.3.3 World iPSC-Derived Natural Killer Cells Average Price by Development and Delivery Format (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World iPSC-Derived Natural Killer Cells Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Cancer Immunotherapy
9.2.2 Autoimmune Disease Therapy
9.2.3 Infectious Disease Research
9.2.4 Drug Screening and Mechanism Studies
9.2.5 Cell Therapy Process Development
9.2.6 Other Applications
9.3 Market Segment by Application
9.3.1 World iPSC-Derived Natural Killer Cells Production by Application (2021-2032)
9.3.2 World iPSC-Derived Natural Killer Cells Production Value by Application (2021-2032)
9.3.3 World iPSC-Derived Natural Killer Cells Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Fate Therapeutics
10.1.1 Fate Therapeutics Details
10.1.2 Fate Therapeutics Major Business
10.1.3 Fate Therapeutics iPSC-Derived Natural Killer Cells Product and Services
10.1.4 Fate Therapeutics iPSC-Derived Natural Killer Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Fate Therapeutics Recent Developments/Updates
10.1.6 Fate Therapeutics Competitive Strengths & Weaknesses
10.2 Century Therapeutics
10.2.1 Century Therapeutics Details
10.2.2 Century Therapeutics Major Business
10.2.3 Century Therapeutics iPSC-Derived Natural Killer Cells Product and Services
10.2.4 Century Therapeutics iPSC-Derived Natural Killer Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Century Therapeutics Recent Developments/Updates
10.2.6 Century Therapeutics Competitive Strengths & Weaknesses
10.3 Cartherics
10.3.1 Cartherics Details
10.3.2 Cartherics Major Business
10.3.3 Cartherics iPSC-Derived Natural Killer Cells Product and Services
10.3.4 Cartherics iPSC-Derived Natural Killer Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.3.5 Cartherics Recent Developments/Updates
10.3.6 Cartherics Competitive Strengths & Weaknesses
10.4 Nuwacell Biotech
10.4.1 Nuwacell Biotech Details
10.4.2 Nuwacell Biotech Major Business
10.4.3 Nuwacell Biotech iPSC-Derived Natural Killer Cells Product and Services
10.4.4 Nuwacell Biotech iPSC-Derived Natural Killer Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.4.5 Nuwacell Biotech Recent Developments/Updates
10.4.6 Nuwacell Biotech Competitive Strengths & Weaknesses
10.5 HebeCell
10.5.1 HebeCell Details
10.5.2 HebeCell Major Business
10.5.3 HebeCell iPSC-Derived Natural Killer Cells Product and Services
10.5.4 HebeCell iPSC-Derived Natural Killer Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.5.5 HebeCell Recent Developments/Updates
10.5.6 HebeCell Competitive Strengths & Weaknesses
10.6 Healios
10.6.1 Healios Details
10.6.2 Healios Major Business
10.6.3 Healios iPSC-Derived Natural Killer Cells Product and Services
10.6.4 Healios iPSC-Derived Natural Killer Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.6.5 Healios Recent Developments/Updates
10.6.6 Healios Competitive Strengths & Weaknesses
10.7 Cytovia Therapeutics
10.7.1 Cytovia Therapeutics Details
10.7.2 Cytovia Therapeutics Major Business
10.7.3 Cytovia Therapeutics iPSC-Derived Natural Killer Cells Product and Services
10.7.4 Cytovia Therapeutics iPSC-Derived Natural Killer Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.7.5 Cytovia Therapeutics Recent Developments/Updates
10.7.6 Cytovia Therapeutics Competitive Strengths & Weaknesses
10.8 Shoreline Biosciences
10.8.1 Shoreline Biosciences Details
10.8.2 Shoreline Biosciences Major Business
10.8.3 Shoreline Biosciences iPSC-Derived Natural Killer Cells Product and Services
10.8.4 Shoreline Biosciences iPSC-Derived Natural Killer Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.8.5 Shoreline Biosciences Recent Developments/Updates
10.8.6 Shoreline Biosciences Competitive Strengths & Weaknesses
10.9 Applied StemCell
10.9.1 Applied StemCell Details
10.9.2 Applied StemCell Major Business
10.9.3 Applied StemCell iPSC-Derived Natural Killer Cells Product and Services
10.9.4 Applied StemCell iPSC-Derived Natural Killer Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.9.5 Applied StemCell Recent Developments/Updates
10.9.6 Applied StemCell Competitive Strengths & Weaknesses
10.10 Cellistic
10.10.1 Cellistic Details
10.10.2 Cellistic Major Business
10.10.3 Cellistic iPSC-Derived Natural Killer Cells Product and Services
10.10.4 Cellistic iPSC-Derived Natural Killer Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.10.5 Cellistic Recent Developments/Updates
10.10.6 Cellistic Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 iPSC-Derived Natural Killer Cells Industry Chain
11.2 iPSC-Derived Natural Killer Cells Upstream Analysis
11.2.1 iPSC-Derived Natural Killer Cells Core Raw Materials
11.2.2 Main Manufacturers of iPSC-Derived Natural Killer Cells Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 iPSC-Derived Natural Killer Cells Production Mode
11.6 iPSC-Derived Natural Killer Cells Procurement Model
11.7 iPSC-Derived Natural Killer Cells Industry Sales Model and Sales Channels
11.7.1 iPSC-Derived Natural Killer Cells Sales Model
11.7.2 iPSC-Derived Natural Killer Cells Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
1.1 iPSC-Derived Natural Killer Cells Introduction
1.2 World iPSC-Derived Natural Killer Cells Supply & Forecast
1.2.1 World iPSC-Derived Natural Killer Cells Production Value (2021 & 2025 & 2032)
1.2.2 World iPSC-Derived Natural Killer Cells Production (2021-2032)
1.2.3 World iPSC-Derived Natural Killer Cells Pricing Trends (2021-2032)
1.3 World iPSC-Derived Natural Killer Cells Production by Region (Based on Production Site)
1.3.1 World iPSC-Derived Natural Killer Cells Production Value by Region (2021-2032)
1.3.2 World iPSC-Derived Natural Killer Cells Production by Region (2021-2032)
1.3.3 World iPSC-Derived Natural Killer Cells Average Price by Region (2021-2032)
1.3.4 North America iPSC-Derived Natural Killer Cells Production (2021-2032)
1.3.5 Europe iPSC-Derived Natural Killer Cells Production (2021-2032)
1.3.6 China iPSC-Derived Natural Killer Cells Production (2021-2032)
1.3.7 Japan iPSC-Derived Natural Killer Cells Production (2021-2032)
1.3.8 India iPSC-Derived Natural Killer Cells Production (2021-2032)
1.3.9 India iPSC-Derived Natural Killer Cells Production (2021-2032)
1.3.10 South America iPSC-Derived Natural Killer Cells Production (2021-2032)
1.3.11 Middle East iPSC-Derived Natural Killer Cells Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 iPSC-Derived Natural Killer Cells Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 iPSC-Derived Natural Killer Cells Major Market Trends
2 DEMAND SUMMARY
2.1 World iPSC-Derived Natural Killer Cells Demand (2021-2032)
2.2 World iPSC-Derived Natural Killer Cells Consumption by Region
2.2.1 World iPSC-Derived Natural Killer Cells Consumption by Region (2021-2026)
2.2.2 World iPSC-Derived Natural Killer Cells Consumption Forecast by Region (2027-2032)
2.3 United States iPSC-Derived Natural Killer Cells Consumption (2021-2032)
2.4 China iPSC-Derived Natural Killer Cells Consumption (2021-2032)
2.5 Europe iPSC-Derived Natural Killer Cells Consumption (2021-2032)
2.6 Japan iPSC-Derived Natural Killer Cells Consumption (2021-2032)
2.7 South Korea iPSC-Derived Natural Killer Cells Consumption (2021-2032)
2.8 ASEAN iPSC-Derived Natural Killer Cells Consumption (2021-2032)
2.9 India iPSC-Derived Natural Killer Cells Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World iPSC-Derived Natural Killer Cells Production Value by Manufacturer (2021-2026)
3.2 World iPSC-Derived Natural Killer Cells Production by Manufacturer (2021-2026)
3.3 World iPSC-Derived Natural Killer Cells Average Price by Manufacturer (2021-2026)
3.4 iPSC-Derived Natural Killer Cells Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global iPSC-Derived Natural Killer Cells Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for iPSC-Derived Natural Killer Cells in 2025
3.5.3 Global Concentration Ratios (CR8) for iPSC-Derived Natural Killer Cells in 2025
3.6 iPSC-Derived Natural Killer Cells Market: Overall Company Footprint Analysis
3.6.1 iPSC-Derived Natural Killer Cells Market: Region Footprint
3.6.2 iPSC-Derived Natural Killer Cells Market: Company Product Type Footprint
3.6.3 iPSC-Derived Natural Killer Cells Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: iPSC-Derived Natural Killer Cells Production Value Comparison
4.1.1 United States VS China: iPSC-Derived Natural Killer Cells Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: iPSC-Derived Natural Killer Cells Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: iPSC-Derived Natural Killer Cells Production Comparison
4.2.1 United States VS China: iPSC-Derived Natural Killer Cells Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: iPSC-Derived Natural Killer Cells Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: iPSC-Derived Natural Killer Cells Consumption Comparison
4.3.1 United States VS China: iPSC-Derived Natural Killer Cells Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: iPSC-Derived Natural Killer Cells Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based iPSC-Derived Natural Killer Cells Manufacturers and Market Share, 2021-2026
4.4.1 United States Based iPSC-Derived Natural Killer Cells Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers iPSC-Derived Natural Killer Cells Production Value (2021-2026)
4.4.3 United States Based Manufacturers iPSC-Derived Natural Killer Cells Production (2021-2026)
4.5 China Based iPSC-Derived Natural Killer Cells Manufacturers and Market Share
4.5.1 China Based iPSC-Derived Natural Killer Cells Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers iPSC-Derived Natural Killer Cells Production Value (2021-2026)
4.5.3 China Based Manufacturers iPSC-Derived Natural Killer Cells Production (2021-2026)
4.6 Rest of World Based iPSC-Derived Natural Killer Cells Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based iPSC-Derived Natural Killer Cells Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers iPSC-Derived Natural Killer Cells Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers iPSC-Derived Natural Killer Cells Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World iPSC-Derived Natural Killer Cells Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Non-Engineered iPSC-Derived NK Cells
5.2.2 CAR-Engineered iPSC-Derived NK Cells
5.2.3 CD16-Enhanced iPSC-Derived NK Cells
5.2.4 Immune-Evasive iPSC-Derived NK Cells
5.2.5 Multi-Functional iPSC-Derived NK Cells
5.3 Market Segment by Type
5.3.1 World iPSC-Derived Natural Killer Cells Production by Type (2021-2032)
5.3.2 World iPSC-Derived Natural Killer Cells Production Value by Type (2021-2032)
5.3.3 World iPSC-Derived Natural Killer Cells Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY CELL SOURCE STRATEGY
6.1 World iPSC-Derived Natural Killer Cells Market Size Overview by Cell Source Strategy: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Cell Source Strategy
6.2.1 Healthy Donor iPSC Line
6.2.2 GMP Master iPSC Bank
6.2.3 Gene-Edited Universal iPSC Line
6.2.4 HLA-Matched iPSC Bank
6.2.5 Patient-Specific iPSC Line
6.3 Market Segment by Cell Source Strategy
6.3.1 World iPSC-Derived Natural Killer Cells Production by Cell Source Strategy (2021-2032)
6.3.2 World iPSC-Derived Natural Killer Cells Production Value by Cell Source Strategy (2021-2032)
6.3.3 World iPSC-Derived Natural Killer Cells Average Price by Cell Source Strategy (2021-2032)
7 MARKET ANALYSIS BY THERAPEUTIC INDICATION
7.1 World iPSC-Derived Natural Killer Cells Market Size Overview by Therapeutic Indication: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Therapeutic Indication
7.2.1 Hematologic Malignancies
7.2.2 Solid Tumors
7.2.3 Autoimmune Diseases
7.2.4 Infectious Diseases
7.2.5 Inflammation and Tissue Repair
7.2.6 Other Research Uses
7.3 Market Segment by Therapeutic Indication
7.3.1 World iPSC-Derived Natural Killer Cells Production by Therapeutic Indication (2021-2032)
7.3.2 World iPSC-Derived Natural Killer Cells Production Value by Therapeutic Indication (2021-2032)
7.3.3 World iPSC-Derived Natural Killer Cells Average Price by Therapeutic Indication (2021-2032)
8 MARKET ANALYSIS BY DEVELOPMENT AND DELIVERY FORMAT
8.1 World iPSC-Derived Natural Killer Cells Market Size Overview by Development and Delivery Format: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Development and Delivery Format
8.2.1 Research-Use Cell Product
8.2.2 Preclinical Candidate
8.2.3 Clinical-Grade Drug Product
8.2.4 CDMO Manufacturing Service
8.2.5 Cell Bank and Starting Material
8.3 Market Segment by Development and Delivery Format
8.3.1 World iPSC-Derived Natural Killer Cells Production by Development and Delivery Format (2021-2032)
8.3.2 World iPSC-Derived Natural Killer Cells Production Value by Development and Delivery Format (2021-2032)
8.3.3 World iPSC-Derived Natural Killer Cells Average Price by Development and Delivery Format (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World iPSC-Derived Natural Killer Cells Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Cancer Immunotherapy
9.2.2 Autoimmune Disease Therapy
9.2.3 Infectious Disease Research
9.2.4 Drug Screening and Mechanism Studies
9.2.5 Cell Therapy Process Development
9.2.6 Other Applications
9.3 Market Segment by Application
9.3.1 World iPSC-Derived Natural Killer Cells Production by Application (2021-2032)
9.3.2 World iPSC-Derived Natural Killer Cells Production Value by Application (2021-2032)
9.3.3 World iPSC-Derived Natural Killer Cells Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Fate Therapeutics
10.1.1 Fate Therapeutics Details
10.1.2 Fate Therapeutics Major Business
10.1.3 Fate Therapeutics iPSC-Derived Natural Killer Cells Product and Services
10.1.4 Fate Therapeutics iPSC-Derived Natural Killer Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Fate Therapeutics Recent Developments/Updates
10.1.6 Fate Therapeutics Competitive Strengths & Weaknesses
10.2 Century Therapeutics
10.2.1 Century Therapeutics Details
10.2.2 Century Therapeutics Major Business
10.2.3 Century Therapeutics iPSC-Derived Natural Killer Cells Product and Services
10.2.4 Century Therapeutics iPSC-Derived Natural Killer Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Century Therapeutics Recent Developments/Updates
10.2.6 Century Therapeutics Competitive Strengths & Weaknesses
10.3 Cartherics
10.3.1 Cartherics Details
10.3.2 Cartherics Major Business
10.3.3 Cartherics iPSC-Derived Natural Killer Cells Product and Services
10.3.4 Cartherics iPSC-Derived Natural Killer Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.3.5 Cartherics Recent Developments/Updates
10.3.6 Cartherics Competitive Strengths & Weaknesses
10.4 Nuwacell Biotech
10.4.1 Nuwacell Biotech Details
10.4.2 Nuwacell Biotech Major Business
10.4.3 Nuwacell Biotech iPSC-Derived Natural Killer Cells Product and Services
10.4.4 Nuwacell Biotech iPSC-Derived Natural Killer Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.4.5 Nuwacell Biotech Recent Developments/Updates
10.4.6 Nuwacell Biotech Competitive Strengths & Weaknesses
10.5 HebeCell
10.5.1 HebeCell Details
10.5.2 HebeCell Major Business
10.5.3 HebeCell iPSC-Derived Natural Killer Cells Product and Services
10.5.4 HebeCell iPSC-Derived Natural Killer Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.5.5 HebeCell Recent Developments/Updates
10.5.6 HebeCell Competitive Strengths & Weaknesses
10.6 Healios
10.6.1 Healios Details
10.6.2 Healios Major Business
10.6.3 Healios iPSC-Derived Natural Killer Cells Product and Services
10.6.4 Healios iPSC-Derived Natural Killer Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.6.5 Healios Recent Developments/Updates
10.6.6 Healios Competitive Strengths & Weaknesses
10.7 Cytovia Therapeutics
10.7.1 Cytovia Therapeutics Details
10.7.2 Cytovia Therapeutics Major Business
10.7.3 Cytovia Therapeutics iPSC-Derived Natural Killer Cells Product and Services
10.7.4 Cytovia Therapeutics iPSC-Derived Natural Killer Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.7.5 Cytovia Therapeutics Recent Developments/Updates
10.7.6 Cytovia Therapeutics Competitive Strengths & Weaknesses
10.8 Shoreline Biosciences
10.8.1 Shoreline Biosciences Details
10.8.2 Shoreline Biosciences Major Business
10.8.3 Shoreline Biosciences iPSC-Derived Natural Killer Cells Product and Services
10.8.4 Shoreline Biosciences iPSC-Derived Natural Killer Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.8.5 Shoreline Biosciences Recent Developments/Updates
10.8.6 Shoreline Biosciences Competitive Strengths & Weaknesses
10.9 Applied StemCell
10.9.1 Applied StemCell Details
10.9.2 Applied StemCell Major Business
10.9.3 Applied StemCell iPSC-Derived Natural Killer Cells Product and Services
10.9.4 Applied StemCell iPSC-Derived Natural Killer Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.9.5 Applied StemCell Recent Developments/Updates
10.9.6 Applied StemCell Competitive Strengths & Weaknesses
10.10 Cellistic
10.10.1 Cellistic Details
10.10.2 Cellistic Major Business
10.10.3 Cellistic iPSC-Derived Natural Killer Cells Product and Services
10.10.4 Cellistic iPSC-Derived Natural Killer Cells Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.10.5 Cellistic Recent Developments/Updates
10.10.6 Cellistic Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 iPSC-Derived Natural Killer Cells Industry Chain
11.2 iPSC-Derived Natural Killer Cells Upstream Analysis
11.2.1 iPSC-Derived Natural Killer Cells Core Raw Materials
11.2.2 Main Manufacturers of iPSC-Derived Natural Killer Cells Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 iPSC-Derived Natural Killer Cells Production Mode
11.6 iPSC-Derived Natural Killer Cells Procurement Model
11.7 iPSC-Derived Natural Killer Cells Industry Sales Model and Sales Channels
11.7.1 iPSC-Derived Natural Killer Cells Sales Model
11.7.2 iPSC-Derived Natural Killer Cells Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
LIST OF TABLES
Table 1. World iPSC-Derived Natural Killer Cells Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World iPSC-Derived Natural Killer Cells Production Value by Region (2021-2026) & (USD Million)
Table 3. World iPSC-Derived Natural Killer Cells Production Value by Region (2027-2032) & (USD Million)
Table 4. World iPSC-Derived Natural Killer Cells Production Value Market Share by Region (2021-2026)
Table 5. World iPSC-Derived Natural Killer Cells Production Value Market Share by Region (2027-2032)
Table 6. World iPSC-Derived Natural Killer Cells Production by Region (2021-2026) & (K Dose)
Table 7. World iPSC-Derived Natural Killer Cells Production by Region (2027-2032) & (K Dose)
Table 8. World iPSC-Derived Natural Killer Cells Production Market Share by Region (2021-2026)
Table 9. World iPSC-Derived Natural Killer Cells Production Market Share by Region (2027-2032)
Table 10. World iPSC-Derived Natural Killer Cells Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World iPSC-Derived Natural Killer Cells Average Price by Region (2027-2032) & (US$/Dose)
Table 12. iPSC-Derived Natural Killer Cells Major Market Trends
Table 13. World iPSC-Derived Natural Killer Cells Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World iPSC-Derived Natural Killer Cells Consumption by Region (2021-2026) & (K Dose)
Table 15. World iPSC-Derived Natural Killer Cells Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World iPSC-Derived Natural Killer Cells Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key iPSC-Derived Natural Killer Cells Producers in 2025
Table 18. World iPSC-Derived Natural Killer Cells Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key iPSC-Derived Natural Killer Cells Producers in 2025
Table 20. World iPSC-Derived Natural Killer Cells Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global iPSC-Derived Natural Killer Cells Company Evaluation Quadrant
Table 22. World iPSC-Derived Natural Killer Cells Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and iPSC-Derived Natural Killer Cells Production Site of Key Manufacturer
Table 24. iPSC-Derived Natural Killer Cells Market: Company Product Type Footprint
Table 25. iPSC-Derived Natural Killer Cells Market: Company Product Application Footprint
Table 26. iPSC-Derived Natural Killer Cells Competitive Factors
Table 27. iPSC-Derived Natural Killer Cells New Entrant and Capacity Expansion Plans
Table 28. iPSC-Derived Natural Killer Cells Mergers & Acquisitions Activity
Table 29. United States VS China iPSC-Derived Natural Killer Cells Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China iPSC-Derived Natural Killer Cells Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China iPSC-Derived Natural Killer Cells Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based iPSC-Derived Natural Killer Cells Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers iPSC-Derived Natural Killer Cells Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers iPSC-Derived Natural Killer Cells Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers iPSC-Derived Natural Killer Cells Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers iPSC-Derived Natural Killer Cells Production Market Share (2021-2026)
Table 37. China Based iPSC-Derived Natural Killer Cells Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers iPSC-Derived Natural Killer Cells Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers iPSC-Derived Natural Killer Cells Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers iPSC-Derived Natural Killer Cells Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers iPSC-Derived Natural Killer Cells Production Market Share (2021-2026)
Table 42. Rest of World Based iPSC-Derived Natural Killer Cells Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers iPSC-Derived Natural Killer Cells Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers iPSC-Derived Natural Killer Cells Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers iPSC-Derived Natural Killer Cells Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers iPSC-Derived Natural Killer Cells Production Market Share (2021-2026)
Table 47. World iPSC-Derived Natural Killer Cells Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World iPSC-Derived Natural Killer Cells Production by Type (2021-2026) & (K Dose)
Table 49. World iPSC-Derived Natural Killer Cells Production by Type (2027-2032) & (K Dose)
Table 50. World iPSC-Derived Natural Killer Cells Production Value by Type (2021-2026) & (USD Million)
Table 51. World iPSC-Derived Natural Killer Cells Production Value by Type (2027-2032) & (USD Million)
Table 52. World iPSC-Derived Natural Killer Cells Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World iPSC-Derived Natural Killer Cells Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World iPSC-Derived Natural Killer Cells Production Value by Cell Source Strategy, (USD Million), 2021 & 2025 & 2032
Table 55. World iPSC-Derived Natural Killer Cells Production by Cell Source Strategy (2021-2026) & (K Dose)
Table 56. World iPSC-Derived Natural Killer Cells Production by Cell Source Strategy (2027-2032) & (K Dose)
Table 57. World iPSC-Derived Natural Killer Cells Production Value by Cell Source Strategy (2021-2026) & (USD Million)
Table 58. World iPSC-Derived Natural Killer Cells Production Value by Cell Source Strategy (2027-2032) & (USD Million)
Table 59. World iPSC-Derived Natural Killer Cells Average Price by Cell Source Strategy (2021-2026) & (US$/Dose)
Table 60. World iPSC-Derived Natural Killer Cells Average Price by Cell Source Strategy (2027-2032) & (US$/Dose)
Table 61. World iPSC-Derived Natural Killer Cells Production Value by Therapeutic Indication, (USD Million), 2021 & 2025 & 2032
Table 62. World iPSC-Derived Natural Killer Cells Production by Therapeutic Indication (2021-2026) & (K Dose)
Table 63. World iPSC-Derived Natural Killer Cells Production by Therapeutic Indication (2027-2032) & (K Dose)
Table 64. World iPSC-Derived Natural Killer Cells Production Value by Therapeutic Indication (2021-2026) & (USD Million)
Table 65. World iPSC-Derived Natural Killer Cells Production Value by Therapeutic Indication (2027-2032) & (USD Million)
Table 66. World iPSC-Derived Natural Killer Cells Average Price by Therapeutic Indication (2021-2026) & (US$/Dose)
Table 67. World iPSC-Derived Natural Killer Cells Average Price by Therapeutic Indication (2027-2032) & (US$/Dose)
Table 68. World iPSC-Derived Natural Killer Cells Production Value by Development and Delivery Format, (USD Million), 2021 & 2025 & 2032
Table 69. World iPSC-Derived Natural Killer Cells Production by Development and Delivery Format (2021-2026) & (K Dose)
Table 70. World iPSC-Derived Natural Killer Cells Production by Development and Delivery Format (2027-2032) & (K Dose)
Table 71. World iPSC-Derived Natural Killer Cells Production Value by Development and Delivery Format (2021-2026) & (USD Million)
Table 72. World iPSC-Derived Natural Killer Cells Production Value by Development and Delivery Format (2027-2032) & (USD Million)
Table 73. World iPSC-Derived Natural Killer Cells Average Price by Development and Delivery Format (2021-2026) & (US$/Dose)
Table 74. World iPSC-Derived Natural Killer Cells Average Price by Development and Delivery Format (2027-2032) & (US$/Dose)
Table 75. World iPSC-Derived Natural Killer Cells Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World iPSC-Derived Natural Killer Cells Production by Application (2021-2026) & (K Dose)
Table 77. World iPSC-Derived Natural Killer Cells Production by Application (2027-2032) & (K Dose)
Table 78. World iPSC-Derived Natural Killer Cells Production Value by Application (2021-2026) & (USD Million)
Table 79. World iPSC-Derived Natural Killer Cells Production Value by Application (2027-2032) & (USD Million)
Table 80. World iPSC-Derived Natural Killer Cells Average Price by Application (2021-2026) & (US$/Dose)
Table 81. World iPSC-Derived Natural Killer Cells Average Price by Application (2027-2032) & (US$/Dose)
Table 82. Fate Therapeutics Basic Information, Manufacturing Base and Competitors
Table 83. Fate Therapeutics Major Business
Table 84. Fate Therapeutics iPSC-Derived Natural Killer Cells Product and Services
Table 85. Fate Therapeutics iPSC-Derived Natural Killer Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Fate Therapeutics Recent Developments/Updates
Table 87. Fate Therapeutics Competitive Strengths & Weaknesses
Table 88. Century Therapeutics Basic Information, Manufacturing Base and Competitors
Table 89. Century Therapeutics Major Business
Table 90. Century Therapeutics iPSC-Derived Natural Killer Cells Product and Services
Table 91. Century Therapeutics iPSC-Derived Natural Killer Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Century Therapeutics Recent Developments/Updates
Table 93. Century Therapeutics Competitive Strengths & Weaknesses
Table 94. Cartherics Basic Information, Manufacturing Base and Competitors
Table 95. Cartherics Major Business
Table 96. Cartherics iPSC-Derived Natural Killer Cells Product and Services
Table 97. Cartherics iPSC-Derived Natural Killer Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. Cartherics Recent Developments/Updates
Table 99. Cartherics Competitive Strengths & Weaknesses
Table 100. Nuwacell Biotech Basic Information, Manufacturing Base and Competitors
Table 101. Nuwacell Biotech Major Business
Table 102. Nuwacell Biotech iPSC-Derived Natural Killer Cells Product and Services
Table 103. Nuwacell Biotech iPSC-Derived Natural Killer Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Nuwacell Biotech Recent Developments/Updates
Table 105. Nuwacell Biotech Competitive Strengths & Weaknesses
Table 106. HebeCell Basic Information, Manufacturing Base and Competitors
Table 107. HebeCell Major Business
Table 108. HebeCell iPSC-Derived Natural Killer Cells Product and Services
Table 109. HebeCell iPSC-Derived Natural Killer Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. HebeCell Recent Developments/Updates
Table 111. HebeCell Competitive Strengths & Weaknesses
Table 112. Healios Basic Information, Manufacturing Base and Competitors
Table 113. Healios Major Business
Table 114. Healios iPSC-Derived Natural Killer Cells Product and Services
Table 115. Healios iPSC-Derived Natural Killer Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 116. Healios Recent Developments/Updates
Table 117. Healios Competitive Strengths & Weaknesses
Table 118. Cytovia Therapeutics Basic Information, Manufacturing Base and Competitors
Table 119. Cytovia Therapeutics Major Business
Table 120. Cytovia Therapeutics iPSC-Derived Natural Killer Cells Product and Services
Table 121. Cytovia Therapeutics iPSC-Derived Natural Killer Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 122. Cytovia Therapeutics Recent Developments/Updates
Table 123. Cytovia Therapeutics Competitive Strengths & Weaknesses
Table 124. Shoreline Biosciences Basic Information, Manufacturing Base and Competitors
Table 125. Shoreline Biosciences Major Business
Table 126. Shoreline Biosciences iPSC-Derived Natural Killer Cells Product and Services
Table 127. Shoreline Biosciences iPSC-Derived Natural Killer Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 128. Shoreline Biosciences Recent Developments/Updates
Table 129. Shoreline Biosciences Competitive Strengths & Weaknesses
Table 130. Applied StemCell Basic Information, Manufacturing Base and Competitors
Table 131. Applied StemCell Major Business
Table 132. Applied StemCell iPSC-Derived Natural Killer Cells Product and Services
Table 133. Applied StemCell iPSC-Derived Natural Killer Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 134. Applied StemCell Recent Developments/Updates
Table 135. Applied StemCell Competitive Strengths & Weaknesses
Table 136. Cellistic Basic Information, Manufacturing Base and Competitors
Table 137. Cellistic Major Business
Table 138. Cellistic iPSC-Derived Natural Killer Cells Product and Services
Table 139. Cellistic iPSC-Derived Natural Killer Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 140. Cellistic Recent Developments/Updates
Table 141. Cellistic Competitive Strengths & Weaknesses
Table 142. Global Key Players of iPSC-Derived Natural Killer Cells Upstream (Raw Materials)
Table 143. Global iPSC-Derived Natural Killer Cells Typical Customers
Table 144. iPSC-Derived Natural Killer Cells Typical Distributors
Table 1. World iPSC-Derived Natural Killer Cells Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World iPSC-Derived Natural Killer Cells Production Value by Region (2021-2026) & (USD Million)
Table 3. World iPSC-Derived Natural Killer Cells Production Value by Region (2027-2032) & (USD Million)
Table 4. World iPSC-Derived Natural Killer Cells Production Value Market Share by Region (2021-2026)
Table 5. World iPSC-Derived Natural Killer Cells Production Value Market Share by Region (2027-2032)
Table 6. World iPSC-Derived Natural Killer Cells Production by Region (2021-2026) & (K Dose)
Table 7. World iPSC-Derived Natural Killer Cells Production by Region (2027-2032) & (K Dose)
Table 8. World iPSC-Derived Natural Killer Cells Production Market Share by Region (2021-2026)
Table 9. World iPSC-Derived Natural Killer Cells Production Market Share by Region (2027-2032)
Table 10. World iPSC-Derived Natural Killer Cells Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World iPSC-Derived Natural Killer Cells Average Price by Region (2027-2032) & (US$/Dose)
Table 12. iPSC-Derived Natural Killer Cells Major Market Trends
Table 13. World iPSC-Derived Natural Killer Cells Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World iPSC-Derived Natural Killer Cells Consumption by Region (2021-2026) & (K Dose)
Table 15. World iPSC-Derived Natural Killer Cells Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World iPSC-Derived Natural Killer Cells Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key iPSC-Derived Natural Killer Cells Producers in 2025
Table 18. World iPSC-Derived Natural Killer Cells Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key iPSC-Derived Natural Killer Cells Producers in 2025
Table 20. World iPSC-Derived Natural Killer Cells Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global iPSC-Derived Natural Killer Cells Company Evaluation Quadrant
Table 22. World iPSC-Derived Natural Killer Cells Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and iPSC-Derived Natural Killer Cells Production Site of Key Manufacturer
Table 24. iPSC-Derived Natural Killer Cells Market: Company Product Type Footprint
Table 25. iPSC-Derived Natural Killer Cells Market: Company Product Application Footprint
Table 26. iPSC-Derived Natural Killer Cells Competitive Factors
Table 27. iPSC-Derived Natural Killer Cells New Entrant and Capacity Expansion Plans
Table 28. iPSC-Derived Natural Killer Cells Mergers & Acquisitions Activity
Table 29. United States VS China iPSC-Derived Natural Killer Cells Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China iPSC-Derived Natural Killer Cells Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China iPSC-Derived Natural Killer Cells Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based iPSC-Derived Natural Killer Cells Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers iPSC-Derived Natural Killer Cells Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers iPSC-Derived Natural Killer Cells Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers iPSC-Derived Natural Killer Cells Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers iPSC-Derived Natural Killer Cells Production Market Share (2021-2026)
Table 37. China Based iPSC-Derived Natural Killer Cells Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers iPSC-Derived Natural Killer Cells Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers iPSC-Derived Natural Killer Cells Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers iPSC-Derived Natural Killer Cells Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers iPSC-Derived Natural Killer Cells Production Market Share (2021-2026)
Table 42. Rest of World Based iPSC-Derived Natural Killer Cells Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers iPSC-Derived Natural Killer Cells Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers iPSC-Derived Natural Killer Cells Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers iPSC-Derived Natural Killer Cells Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers iPSC-Derived Natural Killer Cells Production Market Share (2021-2026)
Table 47. World iPSC-Derived Natural Killer Cells Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World iPSC-Derived Natural Killer Cells Production by Type (2021-2026) & (K Dose)
Table 49. World iPSC-Derived Natural Killer Cells Production by Type (2027-2032) & (K Dose)
Table 50. World iPSC-Derived Natural Killer Cells Production Value by Type (2021-2026) & (USD Million)
Table 51. World iPSC-Derived Natural Killer Cells Production Value by Type (2027-2032) & (USD Million)
Table 52. World iPSC-Derived Natural Killer Cells Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World iPSC-Derived Natural Killer Cells Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World iPSC-Derived Natural Killer Cells Production Value by Cell Source Strategy, (USD Million), 2021 & 2025 & 2032
Table 55. World iPSC-Derived Natural Killer Cells Production by Cell Source Strategy (2021-2026) & (K Dose)
Table 56. World iPSC-Derived Natural Killer Cells Production by Cell Source Strategy (2027-2032) & (K Dose)
Table 57. World iPSC-Derived Natural Killer Cells Production Value by Cell Source Strategy (2021-2026) & (USD Million)
Table 58. World iPSC-Derived Natural Killer Cells Production Value by Cell Source Strategy (2027-2032) & (USD Million)
Table 59. World iPSC-Derived Natural Killer Cells Average Price by Cell Source Strategy (2021-2026) & (US$/Dose)
Table 60. World iPSC-Derived Natural Killer Cells Average Price by Cell Source Strategy (2027-2032) & (US$/Dose)
Table 61. World iPSC-Derived Natural Killer Cells Production Value by Therapeutic Indication, (USD Million), 2021 & 2025 & 2032
Table 62. World iPSC-Derived Natural Killer Cells Production by Therapeutic Indication (2021-2026) & (K Dose)
Table 63. World iPSC-Derived Natural Killer Cells Production by Therapeutic Indication (2027-2032) & (K Dose)
Table 64. World iPSC-Derived Natural Killer Cells Production Value by Therapeutic Indication (2021-2026) & (USD Million)
Table 65. World iPSC-Derived Natural Killer Cells Production Value by Therapeutic Indication (2027-2032) & (USD Million)
Table 66. World iPSC-Derived Natural Killer Cells Average Price by Therapeutic Indication (2021-2026) & (US$/Dose)
Table 67. World iPSC-Derived Natural Killer Cells Average Price by Therapeutic Indication (2027-2032) & (US$/Dose)
Table 68. World iPSC-Derived Natural Killer Cells Production Value by Development and Delivery Format, (USD Million), 2021 & 2025 & 2032
Table 69. World iPSC-Derived Natural Killer Cells Production by Development and Delivery Format (2021-2026) & (K Dose)
Table 70. World iPSC-Derived Natural Killer Cells Production by Development and Delivery Format (2027-2032) & (K Dose)
Table 71. World iPSC-Derived Natural Killer Cells Production Value by Development and Delivery Format (2021-2026) & (USD Million)
Table 72. World iPSC-Derived Natural Killer Cells Production Value by Development and Delivery Format (2027-2032) & (USD Million)
Table 73. World iPSC-Derived Natural Killer Cells Average Price by Development and Delivery Format (2021-2026) & (US$/Dose)
Table 74. World iPSC-Derived Natural Killer Cells Average Price by Development and Delivery Format (2027-2032) & (US$/Dose)
Table 75. World iPSC-Derived Natural Killer Cells Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World iPSC-Derived Natural Killer Cells Production by Application (2021-2026) & (K Dose)
Table 77. World iPSC-Derived Natural Killer Cells Production by Application (2027-2032) & (K Dose)
Table 78. World iPSC-Derived Natural Killer Cells Production Value by Application (2021-2026) & (USD Million)
Table 79. World iPSC-Derived Natural Killer Cells Production Value by Application (2027-2032) & (USD Million)
Table 80. World iPSC-Derived Natural Killer Cells Average Price by Application (2021-2026) & (US$/Dose)
Table 81. World iPSC-Derived Natural Killer Cells Average Price by Application (2027-2032) & (US$/Dose)
Table 82. Fate Therapeutics Basic Information, Manufacturing Base and Competitors
Table 83. Fate Therapeutics Major Business
Table 84. Fate Therapeutics iPSC-Derived Natural Killer Cells Product and Services
Table 85. Fate Therapeutics iPSC-Derived Natural Killer Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Fate Therapeutics Recent Developments/Updates
Table 87. Fate Therapeutics Competitive Strengths & Weaknesses
Table 88. Century Therapeutics Basic Information, Manufacturing Base and Competitors
Table 89. Century Therapeutics Major Business
Table 90. Century Therapeutics iPSC-Derived Natural Killer Cells Product and Services
Table 91. Century Therapeutics iPSC-Derived Natural Killer Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Century Therapeutics Recent Developments/Updates
Table 93. Century Therapeutics Competitive Strengths & Weaknesses
Table 94. Cartherics Basic Information, Manufacturing Base and Competitors
Table 95. Cartherics Major Business
Table 96. Cartherics iPSC-Derived Natural Killer Cells Product and Services
Table 97. Cartherics iPSC-Derived Natural Killer Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. Cartherics Recent Developments/Updates
Table 99. Cartherics Competitive Strengths & Weaknesses
Table 100. Nuwacell Biotech Basic Information, Manufacturing Base and Competitors
Table 101. Nuwacell Biotech Major Business
Table 102. Nuwacell Biotech iPSC-Derived Natural Killer Cells Product and Services
Table 103. Nuwacell Biotech iPSC-Derived Natural Killer Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Nuwacell Biotech Recent Developments/Updates
Table 105. Nuwacell Biotech Competitive Strengths & Weaknesses
Table 106. HebeCell Basic Information, Manufacturing Base and Competitors
Table 107. HebeCell Major Business
Table 108. HebeCell iPSC-Derived Natural Killer Cells Product and Services
Table 109. HebeCell iPSC-Derived Natural Killer Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. HebeCell Recent Developments/Updates
Table 111. HebeCell Competitive Strengths & Weaknesses
Table 112. Healios Basic Information, Manufacturing Base and Competitors
Table 113. Healios Major Business
Table 114. Healios iPSC-Derived Natural Killer Cells Product and Services
Table 115. Healios iPSC-Derived Natural Killer Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 116. Healios Recent Developments/Updates
Table 117. Healios Competitive Strengths & Weaknesses
Table 118. Cytovia Therapeutics Basic Information, Manufacturing Base and Competitors
Table 119. Cytovia Therapeutics Major Business
Table 120. Cytovia Therapeutics iPSC-Derived Natural Killer Cells Product and Services
Table 121. Cytovia Therapeutics iPSC-Derived Natural Killer Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 122. Cytovia Therapeutics Recent Developments/Updates
Table 123. Cytovia Therapeutics Competitive Strengths & Weaknesses
Table 124. Shoreline Biosciences Basic Information, Manufacturing Base and Competitors
Table 125. Shoreline Biosciences Major Business
Table 126. Shoreline Biosciences iPSC-Derived Natural Killer Cells Product and Services
Table 127. Shoreline Biosciences iPSC-Derived Natural Killer Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 128. Shoreline Biosciences Recent Developments/Updates
Table 129. Shoreline Biosciences Competitive Strengths & Weaknesses
Table 130. Applied StemCell Basic Information, Manufacturing Base and Competitors
Table 131. Applied StemCell Major Business
Table 132. Applied StemCell iPSC-Derived Natural Killer Cells Product and Services
Table 133. Applied StemCell iPSC-Derived Natural Killer Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 134. Applied StemCell Recent Developments/Updates
Table 135. Applied StemCell Competitive Strengths & Weaknesses
Table 136. Cellistic Basic Information, Manufacturing Base and Competitors
Table 137. Cellistic Major Business
Table 138. Cellistic iPSC-Derived Natural Killer Cells Product and Services
Table 139. Cellistic iPSC-Derived Natural Killer Cells Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 140. Cellistic Recent Developments/Updates
Table 141. Cellistic Competitive Strengths & Weaknesses
Table 142. Global Key Players of iPSC-Derived Natural Killer Cells Upstream (Raw Materials)
Table 143. Global iPSC-Derived Natural Killer Cells Typical Customers
Table 144. iPSC-Derived Natural Killer Cells Typical Distributors
LIST OF FIGURES
Figure 1. iPSC-Derived Natural Killer Cells Picture
Figure 2. World iPSC-Derived Natural Killer Cells Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World iPSC-Derived Natural Killer Cells Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World iPSC-Derived Natural Killer Cells Production (2021-2032) & (K Dose)
Figure 5. World iPSC-Derived Natural Killer Cells Average Price (2021-2032) & (US$/Dose)
Figure 6. World iPSC-Derived Natural Killer Cells Production Value Market Share by Region (2021-2032)
Figure 7. World iPSC-Derived Natural Killer Cells Production Market Share by Region (2021-2032)
Figure 8. North America iPSC-Derived Natural Killer Cells Production (2021-2032) & (K Dose)
Figure 9. Europe iPSC-Derived Natural Killer Cells Production (2021-2032) & (K Dose)
Figure 10. China iPSC-Derived Natural Killer Cells Production (2021-2032) & (K Dose)
Figure 11. Japan iPSC-Derived Natural Killer Cells Production (2021-2032) & (K Dose)
Figure 12. India iPSC-Derived Natural Killer Cells Production (2021-2032) & (K Dose)
Figure 13. India iPSC-Derived Natural Killer Cells Production (2021-2032) & (K Dose)
Figure 14. South America iPSC-Derived Natural Killer Cells Production (2021-2032) & (K Dose)
Figure 15. Middle East iPSC-Derived Natural Killer Cells Production (2021-2032) & (K Dose)
Figure 16. iPSC-Derived Natural Killer Cells Market Drivers
Figure 17. Factors Affecting Demand
Figure 18. World iPSC-Derived Natural Killer Cells Consumption (2021-2032) & (K Dose)
Figure 19. World iPSC-Derived Natural Killer Cells Consumption Market Share by Region (2021-2032)
Figure 20. United States iPSC-Derived Natural Killer Cells Consumption (2021-2032) & (K Dose)
Figure 21. China iPSC-Derived Natural Killer Cells Consumption (2021-2032) & (K Dose)
Figure 22. Europe iPSC-Derived Natural Killer Cells Consumption (2021-2032) & (K Dose)
Figure 23. Japan iPSC-Derived Natural Killer Cells Consumption (2021-2032) & (K Dose)
Figure 24. South Korea iPSC-Derived Natural Killer Cells Consumption (2021-2032) & (K Dose)
Figure 25. ASEAN iPSC-Derived Natural Killer Cells Consumption (2021-2032) & (K Dose)
Figure 26. India iPSC-Derived Natural Killer Cells Consumption (2021-2032) & (K Dose)
Figure 27. Producer Shipments of iPSC-Derived Natural Killer Cells by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 28. Global Four-firm Concentration Ratios (CR4) for iPSC-Derived Natural Killer Cells Markets in 2025
Figure 29. Global Four-firm Concentration Ratios (CR8) for iPSC-Derived Natural Killer Cells Markets in 2025
Figure 30. United States VS China: iPSC-Derived Natural Killer Cells Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 31. United States VS China: iPSC-Derived Natural Killer Cells Production Market Share Comparison (2021 & 2025 & 2032)
Figure 32. United States VS China: iPSC-Derived Natural Killer Cells Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 33. United States Based Manufacturers iPSC-Derived Natural Killer Cells Production Market Share 2025
Figure 34. China Based Manufacturers iPSC-Derived Natural Killer Cells Production Market Share 2025
Figure 35. Rest of World Based Manufacturers iPSC-Derived Natural Killer Cells Production Market Share 2025
Figure 36. World iPSC-Derived Natural Killer Cells Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 37. World iPSC-Derived Natural Killer Cells Production Value Market Share by Type in 2025
Figure 38. Non-Engineered iPSC-Derived NK Cells
Figure 39. CAR-Engineered iPSC-Derived NK Cells
Figure 40. CD16-Enhanced iPSC-Derived NK Cells
Figure 41. Immune-Evasive iPSC-Derived NK Cells
Figure 42. Multi-Functional iPSC-Derived NK Cells
Figure 43. World iPSC-Derived Natural Killer Cells Production Market Share by Type (2021-2032)
Figure 44. World iPSC-Derived Natural Killer Cells Production Value Market Share by Type (2021-2032)
Figure 45. World iPSC-Derived Natural Killer Cells Average Price by Type (2021-2032) & (US$/Dose)
Figure 46. World iPSC-Derived Natural Killer Cells Production Value by Cell Source Strategy, (USD Million), 2021 & 2025 & 2032
Figure 47. World iPSC-Derived Natural Killer Cells Production Value Market Share by Cell Source Strategy in 2025
Figure 48. Healthy Donor iPSC Line
Figure 49. GMP Master iPSC Bank
Figure 50. Gene-Edited Universal iPSC Line
Figure 51. HLA-Matched iPSC Bank
Figure 52. Patient-Specific iPSC Line
Figure 53. World iPSC-Derived Natural Killer Cells Production Market Share by Cell Source Strategy (2021-2032)
Figure 54. World iPSC-Derived Natural Killer Cells Production Value Market Share by Cell Source Strategy (2021-2032)
Figure 55. World iPSC-Derived Natural Killer Cells Average Price by Cell Source Strategy (2021-2032) & (US$/Dose)
Figure 56. World iPSC-Derived Natural Killer Cells Production Value by Therapeutic Indication, (USD Million), 2021 & 2025 & 2032
Figure 57. World iPSC-Derived Natural Killer Cells Production Value Market Share by Therapeutic Indication in 2025
Figure 58. Hematologic Malignancies
Figure 59. Solid Tumors
Figure 60. Autoimmune Diseases
Figure 61. Infectious Diseases
Figure 62. Inflammation and Tissue Repair
Figure 63. Other Research Uses
Figure 64. World iPSC-Derived Natural Killer Cells Production Market Share by Therapeutic Indication (2021-2032)
Figure 65. World iPSC-Derived Natural Killer Cells Production Value Market Share by Therapeutic Indication (2021-2032)
Figure 66. World iPSC-Derived Natural Killer Cells Average Price by Therapeutic Indication (2021-2032) & (US$/Dose)
Figure 67. World iPSC-Derived Natural Killer Cells Production Value by Development and Delivery Format, (USD Million), 2021 & 2025 & 2032
Figure 68. World iPSC-Derived Natural Killer Cells Production Value Market Share by Development and Delivery Format in 2025
Figure 69. Research-Use Cell Product
Figure 70. Preclinical Candidate
Figure 71. Clinical-Grade Drug Product
Figure 72. CDMO Manufacturing Service
Figure 73. Cell Bank and Starting Material
Figure 74. World iPSC-Derived Natural Killer Cells Production Market Share by Development and Delivery Format (2021-2032)
Figure 75. World iPSC-Derived Natural Killer Cells Production Value Market Share by Development and Delivery Format (2021-2032)
Figure 76. World iPSC-Derived Natural Killer Cells Average Price by Development and Delivery Format (2021-2032) & (US$/Dose)
Figure 77. World iPSC-Derived Natural Killer Cells Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 78. World iPSC-Derived Natural Killer Cells Production Value Market Share by Application in 2025
Figure 79. Cancer Immunotherapy
Figure 80. Autoimmune Disease Therapy
Figure 81. Infectious Disease Research
Figure 82. Drug Screening and Mechanism Studies
Figure 83. Cell Therapy Process Development
Figure 84. Other Applications
Figure 85. World iPSC-Derived Natural Killer Cells Production Market Share by Application (2021-2032)
Figure 86. World iPSC-Derived Natural Killer Cells Production Value Market Share by Application (2021-2032)
Figure 87. World iPSC-Derived Natural Killer Cells Average Price by Application (2021-2032) & (US$/Dose)
Figure 88. iPSC-Derived Natural Killer Cells Industry Chain
Figure 89. iPSC-Derived Natural Killer Cells Procurement Model
Figure 90. iPSC-Derived Natural Killer Cells Sales Model
Figure 91. iPSC-Derived Natural Killer Cells Sales Channels, Direct Sales, and Distribution
Figure 92. Methodology
Figure 93. Research Process and Data Source
Figure 1. iPSC-Derived Natural Killer Cells Picture
Figure 2. World iPSC-Derived Natural Killer Cells Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World iPSC-Derived Natural Killer Cells Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World iPSC-Derived Natural Killer Cells Production (2021-2032) & (K Dose)
Figure 5. World iPSC-Derived Natural Killer Cells Average Price (2021-2032) & (US$/Dose)
Figure 6. World iPSC-Derived Natural Killer Cells Production Value Market Share by Region (2021-2032)
Figure 7. World iPSC-Derived Natural Killer Cells Production Market Share by Region (2021-2032)
Figure 8. North America iPSC-Derived Natural Killer Cells Production (2021-2032) & (K Dose)
Figure 9. Europe iPSC-Derived Natural Killer Cells Production (2021-2032) & (K Dose)
Figure 10. China iPSC-Derived Natural Killer Cells Production (2021-2032) & (K Dose)
Figure 11. Japan iPSC-Derived Natural Killer Cells Production (2021-2032) & (K Dose)
Figure 12. India iPSC-Derived Natural Killer Cells Production (2021-2032) & (K Dose)
Figure 13. India iPSC-Derived Natural Killer Cells Production (2021-2032) & (K Dose)
Figure 14. South America iPSC-Derived Natural Killer Cells Production (2021-2032) & (K Dose)
Figure 15. Middle East iPSC-Derived Natural Killer Cells Production (2021-2032) & (K Dose)
Figure 16. iPSC-Derived Natural Killer Cells Market Drivers
Figure 17. Factors Affecting Demand
Figure 18. World iPSC-Derived Natural Killer Cells Consumption (2021-2032) & (K Dose)
Figure 19. World iPSC-Derived Natural Killer Cells Consumption Market Share by Region (2021-2032)
Figure 20. United States iPSC-Derived Natural Killer Cells Consumption (2021-2032) & (K Dose)
Figure 21. China iPSC-Derived Natural Killer Cells Consumption (2021-2032) & (K Dose)
Figure 22. Europe iPSC-Derived Natural Killer Cells Consumption (2021-2032) & (K Dose)
Figure 23. Japan iPSC-Derived Natural Killer Cells Consumption (2021-2032) & (K Dose)
Figure 24. South Korea iPSC-Derived Natural Killer Cells Consumption (2021-2032) & (K Dose)
Figure 25. ASEAN iPSC-Derived Natural Killer Cells Consumption (2021-2032) & (K Dose)
Figure 26. India iPSC-Derived Natural Killer Cells Consumption (2021-2032) & (K Dose)
Figure 27. Producer Shipments of iPSC-Derived Natural Killer Cells by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 28. Global Four-firm Concentration Ratios (CR4) for iPSC-Derived Natural Killer Cells Markets in 2025
Figure 29. Global Four-firm Concentration Ratios (CR8) for iPSC-Derived Natural Killer Cells Markets in 2025
Figure 30. United States VS China: iPSC-Derived Natural Killer Cells Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 31. United States VS China: iPSC-Derived Natural Killer Cells Production Market Share Comparison (2021 & 2025 & 2032)
Figure 32. United States VS China: iPSC-Derived Natural Killer Cells Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 33. United States Based Manufacturers iPSC-Derived Natural Killer Cells Production Market Share 2025
Figure 34. China Based Manufacturers iPSC-Derived Natural Killer Cells Production Market Share 2025
Figure 35. Rest of World Based Manufacturers iPSC-Derived Natural Killer Cells Production Market Share 2025
Figure 36. World iPSC-Derived Natural Killer Cells Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 37. World iPSC-Derived Natural Killer Cells Production Value Market Share by Type in 2025
Figure 38. Non-Engineered iPSC-Derived NK Cells
Figure 39. CAR-Engineered iPSC-Derived NK Cells
Figure 40. CD16-Enhanced iPSC-Derived NK Cells
Figure 41. Immune-Evasive iPSC-Derived NK Cells
Figure 42. Multi-Functional iPSC-Derived NK Cells
Figure 43. World iPSC-Derived Natural Killer Cells Production Market Share by Type (2021-2032)
Figure 44. World iPSC-Derived Natural Killer Cells Production Value Market Share by Type (2021-2032)
Figure 45. World iPSC-Derived Natural Killer Cells Average Price by Type (2021-2032) & (US$/Dose)
Figure 46. World iPSC-Derived Natural Killer Cells Production Value by Cell Source Strategy, (USD Million), 2021 & 2025 & 2032
Figure 47. World iPSC-Derived Natural Killer Cells Production Value Market Share by Cell Source Strategy in 2025
Figure 48. Healthy Donor iPSC Line
Figure 49. GMP Master iPSC Bank
Figure 50. Gene-Edited Universal iPSC Line
Figure 51. HLA-Matched iPSC Bank
Figure 52. Patient-Specific iPSC Line
Figure 53. World iPSC-Derived Natural Killer Cells Production Market Share by Cell Source Strategy (2021-2032)
Figure 54. World iPSC-Derived Natural Killer Cells Production Value Market Share by Cell Source Strategy (2021-2032)
Figure 55. World iPSC-Derived Natural Killer Cells Average Price by Cell Source Strategy (2021-2032) & (US$/Dose)
Figure 56. World iPSC-Derived Natural Killer Cells Production Value by Therapeutic Indication, (USD Million), 2021 & 2025 & 2032
Figure 57. World iPSC-Derived Natural Killer Cells Production Value Market Share by Therapeutic Indication in 2025
Figure 58. Hematologic Malignancies
Figure 59. Solid Tumors
Figure 60. Autoimmune Diseases
Figure 61. Infectious Diseases
Figure 62. Inflammation and Tissue Repair
Figure 63. Other Research Uses
Figure 64. World iPSC-Derived Natural Killer Cells Production Market Share by Therapeutic Indication (2021-2032)
Figure 65. World iPSC-Derived Natural Killer Cells Production Value Market Share by Therapeutic Indication (2021-2032)
Figure 66. World iPSC-Derived Natural Killer Cells Average Price by Therapeutic Indication (2021-2032) & (US$/Dose)
Figure 67. World iPSC-Derived Natural Killer Cells Production Value by Development and Delivery Format, (USD Million), 2021 & 2025 & 2032
Figure 68. World iPSC-Derived Natural Killer Cells Production Value Market Share by Development and Delivery Format in 2025
Figure 69. Research-Use Cell Product
Figure 70. Preclinical Candidate
Figure 71. Clinical-Grade Drug Product
Figure 72. CDMO Manufacturing Service
Figure 73. Cell Bank and Starting Material
Figure 74. World iPSC-Derived Natural Killer Cells Production Market Share by Development and Delivery Format (2021-2032)
Figure 75. World iPSC-Derived Natural Killer Cells Production Value Market Share by Development and Delivery Format (2021-2032)
Figure 76. World iPSC-Derived Natural Killer Cells Average Price by Development and Delivery Format (2021-2032) & (US$/Dose)
Figure 77. World iPSC-Derived Natural Killer Cells Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 78. World iPSC-Derived Natural Killer Cells Production Value Market Share by Application in 2025
Figure 79. Cancer Immunotherapy
Figure 80. Autoimmune Disease Therapy
Figure 81. Infectious Disease Research
Figure 82. Drug Screening and Mechanism Studies
Figure 83. Cell Therapy Process Development
Figure 84. Other Applications
Figure 85. World iPSC-Derived Natural Killer Cells Production Market Share by Application (2021-2032)
Figure 86. World iPSC-Derived Natural Killer Cells Production Value Market Share by Application (2021-2032)
Figure 87. World iPSC-Derived Natural Killer Cells Average Price by Application (2021-2032) & (US$/Dose)
Figure 88. iPSC-Derived Natural Killer Cells Industry Chain
Figure 89. iPSC-Derived Natural Killer Cells Procurement Model
Figure 90. iPSC-Derived Natural Killer Cells Sales Model
Figure 91. iPSC-Derived Natural Killer Cells Sales Channels, Direct Sales, and Distribution
Figure 92. Methodology
Figure 93. Research Process and Data Source
